Cargando…
S195: IDECABTAGENE VICLEUCEL (IDE-CEL) VS STANDARD REGIMENS IN PATIENTS WITH TRIPLE-CLASS–EXPOSED (TCE) RELAPSED AND REFRACTORY MULTIPLE MYELOMA (RRMM): A KARMMA-3 ANALYSIS IN HIGH-RISK SUBGROUPS
| Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428360/ http://dx.doi.org/10.1097/01.HS9.0000967692.36989.7b |
| _version_ | 1785090450228510720 |
|---|---|
| author | Patel, Krina Rodríguez-Otero, Paula Manier, Salomon Baz, Rachid Raab, Marc S. Cavo, Michele Callander, Natalie Costa, Luciano Moreau, Philippe Solomon, Scott Chen, Christine Raje, Noopur Scheid, Christof Delforge, Michel Larsen, Jeremy Pabst, Thomas Suzuki, Kenshi Truppel-Hartmann, Anna Yang, Zhihong Piasecki, Julia Felten, Jasper Caia, Andrea Cook, Mark Giralt, Sergio Mateos, Maria-Victoria |
| author_facet | Patel, Krina Rodríguez-Otero, Paula Manier, Salomon Baz, Rachid Raab, Marc S. Cavo, Michele Callander, Natalie Costa, Luciano Moreau, Philippe Solomon, Scott Chen, Christine Raje, Noopur Scheid, Christof Delforge, Michel Larsen, Jeremy Pabst, Thomas Suzuki, Kenshi Truppel-Hartmann, Anna Yang, Zhihong Piasecki, Julia Felten, Jasper Caia, Andrea Cook, Mark Giralt, Sergio Mateos, Maria-Victoria |
| author_sort | Patel, Krina |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10428360 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-104283602023-08-17 S195: IDECABTAGENE VICLEUCEL (IDE-CEL) VS STANDARD REGIMENS IN PATIENTS WITH TRIPLE-CLASS–EXPOSED (TCE) RELAPSED AND REFRACTORY MULTIPLE MYELOMA (RRMM): A KARMMA-3 ANALYSIS IN HIGH-RISK SUBGROUPS Patel, Krina Rodríguez-Otero, Paula Manier, Salomon Baz, Rachid Raab, Marc S. Cavo, Michele Callander, Natalie Costa, Luciano Moreau, Philippe Solomon, Scott Chen, Christine Raje, Noopur Scheid, Christof Delforge, Michel Larsen, Jeremy Pabst, Thomas Suzuki, Kenshi Truppel-Hartmann, Anna Yang, Zhihong Piasecki, Julia Felten, Jasper Caia, Andrea Cook, Mark Giralt, Sergio Mateos, Maria-Victoria Hemasphere Oral Sessions Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10428360/ http://dx.doi.org/10.1097/01.HS9.0000967692.36989.7b Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Oral Sessions Patel, Krina Rodríguez-Otero, Paula Manier, Salomon Baz, Rachid Raab, Marc S. Cavo, Michele Callander, Natalie Costa, Luciano Moreau, Philippe Solomon, Scott Chen, Christine Raje, Noopur Scheid, Christof Delforge, Michel Larsen, Jeremy Pabst, Thomas Suzuki, Kenshi Truppel-Hartmann, Anna Yang, Zhihong Piasecki, Julia Felten, Jasper Caia, Andrea Cook, Mark Giralt, Sergio Mateos, Maria-Victoria S195: IDECABTAGENE VICLEUCEL (IDE-CEL) VS STANDARD REGIMENS IN PATIENTS WITH TRIPLE-CLASS–EXPOSED (TCE) RELAPSED AND REFRACTORY MULTIPLE MYELOMA (RRMM): A KARMMA-3 ANALYSIS IN HIGH-RISK SUBGROUPS |
| title | S195: IDECABTAGENE VICLEUCEL (IDE-CEL) VS STANDARD REGIMENS IN PATIENTS WITH TRIPLE-CLASS–EXPOSED (TCE) RELAPSED AND REFRACTORY MULTIPLE MYELOMA (RRMM): A KARMMA-3 ANALYSIS IN HIGH-RISK SUBGROUPS |
| title_full | S195: IDECABTAGENE VICLEUCEL (IDE-CEL) VS STANDARD REGIMENS IN PATIENTS WITH TRIPLE-CLASS–EXPOSED (TCE) RELAPSED AND REFRACTORY MULTIPLE MYELOMA (RRMM): A KARMMA-3 ANALYSIS IN HIGH-RISK SUBGROUPS |
| title_fullStr | S195: IDECABTAGENE VICLEUCEL (IDE-CEL) VS STANDARD REGIMENS IN PATIENTS WITH TRIPLE-CLASS–EXPOSED (TCE) RELAPSED AND REFRACTORY MULTIPLE MYELOMA (RRMM): A KARMMA-3 ANALYSIS IN HIGH-RISK SUBGROUPS |
| title_full_unstemmed | S195: IDECABTAGENE VICLEUCEL (IDE-CEL) VS STANDARD REGIMENS IN PATIENTS WITH TRIPLE-CLASS–EXPOSED (TCE) RELAPSED AND REFRACTORY MULTIPLE MYELOMA (RRMM): A KARMMA-3 ANALYSIS IN HIGH-RISK SUBGROUPS |
| title_short | S195: IDECABTAGENE VICLEUCEL (IDE-CEL) VS STANDARD REGIMENS IN PATIENTS WITH TRIPLE-CLASS–EXPOSED (TCE) RELAPSED AND REFRACTORY MULTIPLE MYELOMA (RRMM): A KARMMA-3 ANALYSIS IN HIGH-RISK SUBGROUPS |
| title_sort | s195: idecabtagene vicleucel (ide-cel) vs standard regimens in patients with triple-class–exposed (tce) relapsed and refractory multiple myeloma (rrmm): a karmma-3 analysis in high-risk subgroups |
| topic | Oral Sessions |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428360/ http://dx.doi.org/10.1097/01.HS9.0000967692.36989.7b |
| work_keys_str_mv | AT patelkrina s195idecabtagenevicleucelidecelvsstandardregimensinpatientswithtripleclassexposedtcerelapsedandrefractorymultiplemyelomarrmmakarmma3analysisinhighrisksubgroups AT rodriguezoteropaula s195idecabtagenevicleucelidecelvsstandardregimensinpatientswithtripleclassexposedtcerelapsedandrefractorymultiplemyelomarrmmakarmma3analysisinhighrisksubgroups AT maniersalomon s195idecabtagenevicleucelidecelvsstandardregimensinpatientswithtripleclassexposedtcerelapsedandrefractorymultiplemyelomarrmmakarmma3analysisinhighrisksubgroups AT bazrachid s195idecabtagenevicleucelidecelvsstandardregimensinpatientswithtripleclassexposedtcerelapsedandrefractorymultiplemyelomarrmmakarmma3analysisinhighrisksubgroups AT raabmarcs s195idecabtagenevicleucelidecelvsstandardregimensinpatientswithtripleclassexposedtcerelapsedandrefractorymultiplemyelomarrmmakarmma3analysisinhighrisksubgroups AT cavomichele s195idecabtagenevicleucelidecelvsstandardregimensinpatientswithtripleclassexposedtcerelapsedandrefractorymultiplemyelomarrmmakarmma3analysisinhighrisksubgroups AT callandernatalie s195idecabtagenevicleucelidecelvsstandardregimensinpatientswithtripleclassexposedtcerelapsedandrefractorymultiplemyelomarrmmakarmma3analysisinhighrisksubgroups AT costaluciano s195idecabtagenevicleucelidecelvsstandardregimensinpatientswithtripleclassexposedtcerelapsedandrefractorymultiplemyelomarrmmakarmma3analysisinhighrisksubgroups AT moreauphilippe s195idecabtagenevicleucelidecelvsstandardregimensinpatientswithtripleclassexposedtcerelapsedandrefractorymultiplemyelomarrmmakarmma3analysisinhighrisksubgroups AT solomonscott s195idecabtagenevicleucelidecelvsstandardregimensinpatientswithtripleclassexposedtcerelapsedandrefractorymultiplemyelomarrmmakarmma3analysisinhighrisksubgroups AT chenchristine s195idecabtagenevicleucelidecelvsstandardregimensinpatientswithtripleclassexposedtcerelapsedandrefractorymultiplemyelomarrmmakarmma3analysisinhighrisksubgroups AT rajenoopur s195idecabtagenevicleucelidecelvsstandardregimensinpatientswithtripleclassexposedtcerelapsedandrefractorymultiplemyelomarrmmakarmma3analysisinhighrisksubgroups AT scheidchristof s195idecabtagenevicleucelidecelvsstandardregimensinpatientswithtripleclassexposedtcerelapsedandrefractorymultiplemyelomarrmmakarmma3analysisinhighrisksubgroups AT delforgemichel s195idecabtagenevicleucelidecelvsstandardregimensinpatientswithtripleclassexposedtcerelapsedandrefractorymultiplemyelomarrmmakarmma3analysisinhighrisksubgroups AT larsenjeremy s195idecabtagenevicleucelidecelvsstandardregimensinpatientswithtripleclassexposedtcerelapsedandrefractorymultiplemyelomarrmmakarmma3analysisinhighrisksubgroups AT pabstthomas s195idecabtagenevicleucelidecelvsstandardregimensinpatientswithtripleclassexposedtcerelapsedandrefractorymultiplemyelomarrmmakarmma3analysisinhighrisksubgroups AT suzukikenshi s195idecabtagenevicleucelidecelvsstandardregimensinpatientswithtripleclassexposedtcerelapsedandrefractorymultiplemyelomarrmmakarmma3analysisinhighrisksubgroups AT truppelhartmannanna s195idecabtagenevicleucelidecelvsstandardregimensinpatientswithtripleclassexposedtcerelapsedandrefractorymultiplemyelomarrmmakarmma3analysisinhighrisksubgroups AT yangzhihong s195idecabtagenevicleucelidecelvsstandardregimensinpatientswithtripleclassexposedtcerelapsedandrefractorymultiplemyelomarrmmakarmma3analysisinhighrisksubgroups AT piaseckijulia s195idecabtagenevicleucelidecelvsstandardregimensinpatientswithtripleclassexposedtcerelapsedandrefractorymultiplemyelomarrmmakarmma3analysisinhighrisksubgroups AT feltenjasper s195idecabtagenevicleucelidecelvsstandardregimensinpatientswithtripleclassexposedtcerelapsedandrefractorymultiplemyelomarrmmakarmma3analysisinhighrisksubgroups AT caiaandrea s195idecabtagenevicleucelidecelvsstandardregimensinpatientswithtripleclassexposedtcerelapsedandrefractorymultiplemyelomarrmmakarmma3analysisinhighrisksubgroups AT cookmark s195idecabtagenevicleucelidecelvsstandardregimensinpatientswithtripleclassexposedtcerelapsedandrefractorymultiplemyelomarrmmakarmma3analysisinhighrisksubgroups AT giraltsergio s195idecabtagenevicleucelidecelvsstandardregimensinpatientswithtripleclassexposedtcerelapsedandrefractorymultiplemyelomarrmmakarmma3analysisinhighrisksubgroups AT mateosmariavictoria s195idecabtagenevicleucelidecelvsstandardregimensinpatientswithtripleclassexposedtcerelapsedandrefractorymultiplemyelomarrmmakarmma3analysisinhighrisksubgroups |